Thymosin beta4 triggers an epithelial-mesenchymal transition in colorectal carcinoma by upregulating integrin-linked kinase

Oncogene. 2007 Apr 26;26(19):2781-90. doi: 10.1038/sj.onc.1210078. Epub 2006 Oct 30.

Abstract

The epithelial-mesenchymal transition (EMT) is crucial for the invasion and metastasis of many epithelial tumors including colorectal carcinoma (CRC). In the present study, a scattering and fibroblastic morphology with reduced intercellular contacts was found in the SW480 colon cancer cells overexpressing the gene encoding thymosin beta4 (Tbeta4), which was accompanied by a loss of E-cadherin as well as a cytosolic accumulation of beta-catenin, two most prominent markers of EMT. Whereas E-cadherin downregulation was likely to be accounted by a ZEB1-mediated transcriptional repression, the accumulation of beta-catenin was a result of glycogen synthase kinase-3beta inactivation mediated by integrin-linked kinase (ILK) and/or its downstream effector, Akt. Intriguingly, ILK upregulation in Tbeta4-overexpressing SW480 cells seemed to be attributed mainly to a stabilization of this kinase by complexing with particularly interesting new Cys-His protein (PINCH) more efficiently. In the meantime, a strong correlation between the expression levels of Tbeta4, ILK and E-cadherin in CRC patients was also revealed by immunohistochemical analysis. Taken together, these data suggest a novel role of Tbeta4 in promoting CRC progression by inducing an EMT in tumor cells via upregulating ILK and consequentially its signal transduction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptor Proteins, Signal Transducing
  • Animals
  • Cadherins / metabolism
  • Casein Kinase I / metabolism
  • Colonic Neoplasms / enzymology*
  • Colonic Neoplasms / pathology
  • Colorectal Neoplasms / metabolism*
  • Colorectal Neoplasms / secondary
  • DNA-Binding Proteins / metabolism
  • Enzyme Inhibitors / pharmacology
  • Epithelial Cells / metabolism*
  • Fibroblasts / cytology
  • Fibroblasts / metabolism
  • Fibroblasts / pathology
  • Glycogen Synthase Kinase 3 / metabolism
  • Homeodomain Proteins / genetics
  • Homeodomain Proteins / metabolism
  • Humans
  • Immunoenzyme Techniques
  • LIM Domain Proteins
  • Membrane Proteins
  • Mesoderm / cytology*
  • Mesoderm / metabolism
  • Mice
  • Phosphatidylinositol 3-Kinases / metabolism
  • Phosphoinositide-3 Kinase Inhibitors
  • Phosphorylation
  • Protein Serine-Threonine Kinases / genetics
  • Protein Serine-Threonine Kinases / metabolism*
  • RNA, Antisense / pharmacology
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Reverse Transcriptase Polymerase Chain Reaction
  • Signal Transduction
  • Thymosin / antagonists & inhibitors
  • Thymosin / genetics
  • Thymosin / pharmacology*
  • Transcription Factors / genetics
  • Transcription Factors / metabolism
  • Transcription, Genetic
  • Transfection
  • Tumor Cells, Cultured
  • Up-Regulation
  • Zinc Finger E-box-Binding Homeobox 1
  • beta Catenin / metabolism

Substances

  • Adaptor Proteins, Signal Transducing
  • Cadherins
  • DNA-Binding Proteins
  • Enzyme Inhibitors
  • Homeodomain Proteins
  • LIM Domain Proteins
  • LIMS1 protein, human
  • Membrane Proteins
  • Phosphoinositide-3 Kinase Inhibitors
  • RNA, Antisense
  • RNA, Messenger
  • Transcription Factors
  • ZEB1 protein, human
  • Zinc Finger E-box-Binding Homeobox 1
  • beta Catenin
  • thymosin beta(4)
  • Thymosin
  • integrin-linked kinase
  • Casein Kinase I
  • Protein Serine-Threonine Kinases
  • Glycogen Synthase Kinase 3